TABATON, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 19.471
AS - Asia 1.778
NA - Nord America 1.206
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 31
Totale 22.742
Nazione #
IT - Italia 19.152
US - Stati Uniti d'America 1.121
SG - Singapore 768
CN - Cina 466
VN - Vietnam 281
FR - Francia 160
BR - Brasile 108
BD - Bangladesh 88
HK - Hong Kong 68
DE - Germania 37
FI - Finlandia 32
CA - Canada 31
AR - Argentina 30
JP - Giappone 21
CH - Svizzera 17
MX - Messico 16
IQ - Iraq 13
IN - India 12
EC - Ecuador 11
GB - Regno Unito 11
ID - Indonesia 9
NL - Olanda 9
CO - Colombia 8
ZA - Sudafrica 8
CL - Cile 7
CR - Costa Rica 7
IE - Irlanda 7
RU - Federazione Russa 7
UA - Ucraina 7
JM - Giamaica 6
SA - Arabia Saudita 6
SV - El Salvador 6
EG - Egitto 5
HN - Honduras 5
PK - Pakistan 5
PY - Paraguay 5
TH - Thailandia 5
PH - Filippine 4
PL - Polonia 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
DO - Repubblica Dominicana 3
ES - Italia 3
GT - Guatemala 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
TN - Tunisia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MM - Myanmar 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
RO - Romania 2
SE - Svezia 2
SN - Senegal 2
TR - Turchia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BM - Bermuda 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 22.662
Città #
Genova 12.792
Genoa 3.730
Rapallo 1.513
Vado Ligure 996
Singapore 335
San Jose 300
Lauterbourg 155
Ashburn 132
Ho Chi Minh City 92
Hanoi 71
New York 64
Hong Kong 63
Beijing 56
Bordighera 54
Santa Clara 42
Frankfurt am Main 33
Helsinki 32
Los Angeles 20
Tokyo 20
Zurich 17
Tianjin 15
Council Bluffs 14
Da Nang 13
Haiphong 13
Houston 12
Phoenix 12
Amsterdam 9
Biên Hòa 9
Chicago 9
Dallas 9
Guangzhou 8
Orem 8
Rome 8
São Paulo 8
Buffalo 7
Mexico City 7
Milan 7
Toronto 7
Dublin 6
Miami 6
Philadelphia 6
San Salvador 6
Thái Bình 6
Atlanta 5
Bologna 5
Detroit 5
Kingston 5
Newark 5
San José 5
Seattle 5
Alpharetta 4
Belo Horizonte 4
Cape Town 4
Cardiff 4
Catania 4
Chennai 4
Des Moines 4
Fredericksburg 4
Guayaquil 4
Jersey City 4
Mobile 4
Montreal 4
Quito 4
Riverside 4
Warsaw 4
Washington 4
Amman 3
Baku 3
Brasília 3
Caracas 3
Charlotte 3
Concepción 3
Denver 3
Goiânia 3
Ha Long 3
Highland 3
Hải Dương 3
Juiz de Fora 3
Kansas City 3
Lafayette 3
Lancaster 3
Madrid 3
Nairobi 3
Ninh Bình 3
Quảng Ngãi 3
Shenzhen 3
Stockton 3
Taichung 3
Albany 2
Alexandria 2
Anderson 2
Astana 2
Baghdad 2
Baltimore 2
Basra 2
Birmingham 2
Boardman 2
Bossier City 2
Boston 2
Brampton 2
Totale 20.911
Nome #
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 256
Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation 230
A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. 206
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. 199
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 196
Lipoperoxidation is selectively involved in progressive supranuclear palsy 194
Early glycoxidation damage in brains from Down’s syndrome 189
Survival rate in Patients affected by Dementia followed by memory clinics (UVA) in Italy 189
Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment. 188
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy 187
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 185
Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway. 185
Direct immunofluorescence in sural nerve biopsies. 184
Balance features in Alzheimer's disease and amnestic mild cognitive impairment 183
RNA polymerase III drives alternative splicing of the Potassium Channel Interacting Protein contributing to brain complexity and neurodegeneration 181
JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. 179
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 178
GFAP expression of human Schwann cells in tissue culture. 178
Alternative, non-secretase processing of Alzheimer’s b-amyloid precursor protein during apoptosis by Caspase-6 and-8 178
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 175
Fibroblasts from FAD-linked presenilin 1 mutations display a normal unfolded protein response but overproduce Abeta42 in response to tunicamycin 174
Oxidative stress induces increase in intracellular amyloid-protein production and selective activation of I and II PKCs in NT2 cells 174
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein 174
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 173
Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation 172
Mutant presenilin 1 increases the expression and activity of BACE1. 171
Elevation of βAmyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment. 170
The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease 169
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 165
Schwann cell GFAP expression increases in axonal neuropathies. 163
Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment. 162
Oxidative stress increase expression and activity of BACE in NT2 neurons 161
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment 161
Motor and sensory evoked potentials in progressive supranuclear palsy. 160
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules 159
A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1 158
Beta-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. 157
HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. 157
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy. 156
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 156
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation 154
Amyloid-b deposition in Alzheimer transgenic mice is associated with oxidative stress. 153
The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment 153
Position paper of the Italian Society for the study of Dementias (Sindem) on the proposal of a new Lexicon on Alzheimer disease. 152
CSF and serum IgG and albumin in schizophrenics 152
A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. 151
Beta-amyloid is different in normal aging and in Alzheimer's disease 151
Aβ 1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation. 151
Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis 150
Relationship between Balance and Cognitive Performance in Older People 150
Presence of soluble amyloid beta peptide precedes amyloid plaque formation in Down's syndrome 149
Neuronal apoptosis is accompanied by selective intracellular A-beta production and APP caspase cleavage 149
Creutzfeldt-Jakob disease in the city and district of Genoa: estimated mortality rate in the six year period 1974-1979. 148
Amyloid-β Production: Major Link Between Oxidative Stress and BACE1. 148
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration 147
Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment 147
Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects 147
A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene) 146
The 14-3-3 protein in multiple sclerosis: a marker of disease severity. 145
Early myoclonus and quasiperiodic EEG changes in non-familial Alzheimer's disease. 145
The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease 145
Oxidative damage in the olfactory system in Alzheimer’s disease. 144
Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. 143
Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. 143
Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice 143
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome brains 142
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. 142
Opposite role of apolipoprotein E in normal brain and Alzheimer's disease 141
Amyloid beta protein deposition in brains from elderly subjects with leukoaraiosis. 141
Peripheral neuropathy in Cockayne syndrome. 141
Generation of an apoptotic intracellular peptdide by g-secretase cleavage of Alzheimer’s amyliod b-protein precursor. 139
The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons. 136
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells 135
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases. 134
Microarray analysis in Alzheimer’s disease and normal aging 133
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism 133
Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation. 133
A simple, inexpensive, and precise spectrophotometric method for evaluating the concentration of ascorbic acid in CSF samples: data from different neurological pathologies. 133
Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations. 132
Oxidative stress in Alzheimer disease: A possibility for prevention. 132
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. 132
Non traumatic dissecting aneurysm of the basilar artery 131
Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells 130
The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies 130
Mitochondrial abnormalities in Alzheimer disease. 129
Oxidative stress and neuronal adaptation in Alzheimer disease : the role of SAPK pathways. 128
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 128
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. 128
Italian multicenter study of dementia: a pathologically verified case of Alzheimer disease. 127
Plasma levels of amyloid beta 40 and 42 are independent from apoE genotype and mental retardation in Down syndrome 126
Skin fibroblasts in Huntington's disease. An electron microscopic study. 125
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (Progressive Supranuclear Palsy) 124
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 123
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. 123
Neurosyphilis presenting as a progressive supranuclear palsy 122
Is amyloid beta-protein glycated in Alzheimer disease? 122
Polyglucosan bodies in the sural nerve of a diabetic patient with polyneuropathy. 122
Periodic lateralized discharges in Creutzfeldt-Jakob disease: serial electroencephalographic studies. 122
Validity and reliability of the preliminary NINDS neuropathologic criteria for Progressive Supranuclear Palsy and related disorders 122
Zoster sine herpete causing encephalomyelitis. 121
Totale 15.400
Categoria #
all - tutte 66.269
article - articoli 66.269
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.016 67 134 160 259 87 98 91 507 86 221 70 236
2022/20231.825 199 123 11 164 305 344 22 139 340 8 154 16
2023/2024769 37 133 7 88 75 89 41 80 43 8 53 115
2024/20252.442 52 202 67 159 341 263 209 370 108 127 240 304
2025/20264.388 540 107 265 450 573 506 773 185 255 378 177 179
2026/2027451 451 0 0 0 0 0 0 0 0 0 0 0
Totale 22.742